Promising new treatment for pancreatic cancer doubles survival rates
Summary
A new experimental drug for pancreatic cancer has been developed. It is taken once daily and helps patients live longer by slowing down the cancer's growth.Key Facts
- The drug targets pancreatic cancer, which is one of the deadliest cancers.
- It is an experimental treatment, meaning it is still being studied.
- Patients take the drug once a day.
- The drug works by slowing the progression of the cancer.
- The treatment has shown promising results after many years of research.
- Dr. Rachna Shroff, a cancer expert, is involved in studying this drug.
- The research is connected to the University of Arizona Comprehensive Cancer Center.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.